---
title: "Taysha Gene Therapies, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d
json: https://whiteintel.dev/api/public/dossier/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d
identifier: sec:0001806310
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Taysha Gene Therapies, Inc.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001806310`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d  

## Ownership & control

### Owners / controllers

- **Alam Kamran** (officer) — https://whiteintel.dev/entity/190e2221-8d71-5b43-a668-f0e41c17980d
- **Nolan Sean P.** (officer) — https://whiteintel.dev/entity/973adacd-6ece-5af6-8afc-6ee080d963b2
- **Nagendran Sukumar** (officer) — https://whiteintel.dev/entity/1a32cdd2-fa70-57bc-a590-de5048b9f938
- **Alam Kamran** (officer) — https://whiteintel.dev/entity/190e2221-8d71-5b43-a668-f0e41c17980d
- **Nagendran Sukumar** (director) — https://whiteintel.dev/entity/1a32cdd2-fa70-57bc-a590-de5048b9f938
- **Sepp-Lorenzino Laura** (director) — https://whiteintel.dev/entity/454d159a-174a-53c8-98a8-12548262d8f0
- **Nagendran Sukumar** (officer) — https://whiteintel.dev/entity/1a32cdd2-fa70-57bc-a590-de5048b9f938
- **LONG ALISON S** (director) — https://whiteintel.dev/entity/b504f2c0-0122-502d-b0f3-d01f5d6cdb3e
- **DONENBERG PHILIP B** (director) — https://whiteintel.dev/entity/f0bf21b4-cd4d-5073-a7b3-2318fd5caf3e
- **STALFORT JOHN A III** (director) — https://whiteintel.dev/entity/7d385687-1049-5c11-8a7b-3f96785aab30
- **Nolan Sean P.** (officer) — https://whiteintel.dev/entity/973adacd-6ece-5af6-8afc-6ee080d963b2
- **Alam Kamran** (officer) — https://whiteintel.dev/entity/190e2221-8d71-5b43-a668-f0e41c17980d
- **Nolan Sean P.** (director) — https://whiteintel.dev/entity/973adacd-6ece-5af6-8afc-6ee080d963b2
- **MANNING PAUL B** (tenpercentowner) — https://whiteintel.dev/entity/60ef7371-c1b7-584b-9e77-14f022fd6268
- **SESSION R.A. II** (tenpercentowner) — https://whiteintel.dev/entity/22ccaa5b-1fb7-5a3a-8903-a9b8399467a8
- **REAPE KATHLEEN** (director) — https://whiteintel.dev/entity/7e68ae7f-8539-57f7-a436-09cc496ff66f
- **AUDENTES THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/b3cefdfe-f536-5019-bb42-7e2793f88657
- **SESSION R.A. II** (director) — https://whiteintel.dev/entity/22ccaa5b-1fb7-5a3a-8903-a9b8399467a8
- **ASTELLAS PHARMA INC.** (tenpercentowner) — https://whiteintel.dev/entity/8c1e6426-faf7-5587-b39f-8ad6931cbd8a
- **MANNING PAUL B** (director) — https://whiteintel.dev/entity/60ef7371-c1b7-584b-9e77-14f022fd6268
- **PRASAD SUYASH** (officer) — https://whiteintel.dev/entity/84f5d415-9cb7-5bde-9d8a-0ce926911eab
- **SESSION R.A. II** (officer) — https://whiteintel.dev/entity/22ccaa5b-1fb7-5a3a-8903-a9b8399467a8

### UBO chain (walk to the ultimate owner)

A **71-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Taysha Gene Therapies, Inc.**. Human view: https://whiteintel.dev/entity/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d · Structured JSON: https://whiteintel.dev/api/public/dossier/a20cfdb6-5b68-5431-8c84-e5ffeecd6a8d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._